# Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial

> **NCT01894815** · PHASE3 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 245 (actual)

## Conditions studied

- Major Depressive Disorder
- Major Depressive Disorder, Recurrent, Unspecified
- Major Depressive Disorder, Single Episode, Unspecified

## Interventions

- **DRUG:** Escitalopram oxalate
- **DEVICE:** transcranial direct current stimulation
- **OTHER:** Sham tDCS + Placebo Pill

## Key facts

- **NCT ID:** NCT01894815
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-07
- **Final completion:** 2016-11
- **Target enrollment:** 245 (ACTUAL)
- **Last updated:** 2016-12-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01894815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01894815, "Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01894815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*